Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
PBS Biotech Names Martin Simonetti as New CEO for Growth
PBS Biotech, a leading provider of innovative single-use bioreactor systems and bioprocess development services, has announced the appointment of Martin Simonetti as Chief Executive Officer, effective October 27, 2025. Simonetti brings over 40 years of experience in the biotechnology industry, including executive leadership, strategic financing, and managing large-scale pharmaceutical collaborations. As part of the company’s leadership transition, PBS founder Dr. Brian Lee will shift to the role of Chief Technology Officer, focusing on technology strategy and product innovation while remaining Chairman of the Board.
Kaigene Signs Exclusive Licensing Deal with Celltrion for Antibody Therapy
Kaigene Inc., a biotechnology company based in the United States and focused on developing next-generation antibody therapies for autoimmune disorders, has announced an exclusive global licensing agreement with Celltrion Inc., a leading international biopharmaceutical company. The agreement covers two of Kaigene’s nonclinical-stage assets, KG006 and KG002, allowing Celltrion to develop and commercialize these therapies worldwide, with the exception of Greater China and Japan for KG006.
Sky Labs Attracts Investment With Omron Subsidiary OMRON VENTURES
On November 4, 2025, Sky Labs announced that it has received investment from OMRON Ventures, which is part of the Omron Group and based in Minato-ku, Tokyo. This investment is not just financial—it represents a deeper strategic connection between the two companies aimed at growing their business on a global scale.
Esperion Appoints Industry Veteran John Harlow as Chief Commercial Officer
Esperion, announced that John Harlow will join the company as Chief Commercial Officer, effective November 17, 2025. In his new role, Mr. Harlow will become part of Esperion’s Executive Leadership Team and report directly to Sheldon Koenig, the President and CEO.
Walgreens Launches Enhanced Respiratory Index to Track Flu and COVID-19 Hotspots
Walgreens has launched the 2025-2026 Respiratory Index, an interactive online tool that tracks flu and COVID-19 activity nationwide using prescription, testing and over the counter (OTC) product purchase data from Walgreens locations nationwide. This unique tool builds on more than a decade of insights from the Walgreens Flu Index to now offer a more comprehensive view of respiratory illness trends across the U.S., helping the public, healthcare providers, and health officials make more informed decisions throughout the respiratory virus season.
To share your insights, please write to us at tony@intentamplify.com
